X4 Pharmaceuticals
Sarah Austin is a Senior Manager in Finance at X4 Pharmaceuticals, where responsibilities include leading the budget process, collaborating on long-range planning, and preparing financial reports and presentations for the Board of Directors and Senior Management. With prior roles as Finance Manager and Senior Financial Analyst at the same company, Sarah has developed expertise in financial analysis and strategy. Previous experience includes serving as an Assurance Associate at PwC, focusing on financial statement audits for real estate investment firms, and assisting in various academic support roles at Boston College. Sarah holds a Bachelor of Business Administration in Accounting from Boston College.
X4 Pharmaceuticals
3 followers
X4 Pharmaceuticals is developing novel therapeutics designed to improve immune cell trafficking to treat rare diseases, including primary immunodeficiencies and certain cancers. The company’s oral small molecule drug candidates antagonize the CXCR4 pathway, which plays a central role in immune surveillance.